DOC, MC, CI for Test 4 Flashcards
(38 cards)
(Lecture 1)
An anticonvulsant used in Bipolar Disorder, this is the current DOC in most manic indications
Valproic Acid/ Divalproex sodium
Effective as lithium in acute and prophylactic management
PREFERRED FOR RAPID CYCLERS (>4 MANIC EPISODES /YR)
PREGNANCY CAT D
(Lecture 1) This class of drugs is used first line in treating: -Depression -OCD -Panic Disorder -Social Phobia -PTSD -Premenstrual Dysphoric Disorder (PDD) -Generalized Anxiety Disorder
Selective Serotonin Reuptake Inhibitors (SSRIs)
(EX: Fluoxetine; Fluvoxamine; Paroxetine; Sertraline; Citalopram; Escitalopram; Vilazodone; Vortioxetine
- not as lethal in cases of OD as are TCAs
- ONSET OF ACTION TAKES 3-8 WEEKS (OR LONGER IN SOME CASES)
(Lecture 1)
This drug is used as a first line treatment of PTSD along with SSRIs
Venlafaxine (an SNRI)
-WORKS AS AN SSRI AT DOSES ~75mg/day; SNRI AT > 225mg/day
ADE: GI… INCREASE IN BP… ABRUPT DISCONTINUATION can yield withdrawal syndrome similar to SSRI w/d (taper dose)
CI: MAOIs and -triptans (serotonin syndrome)
(Lecture 1)
This drug is a 2nd line agent for MDD
Desvenlafaxine (as SNRI)
is an active metabolite of venlafaxine… no advantage over venlafaxine
(Lecture 1)
This drug is considered a 2nd or 3rd line agent used for anxious depression or in SSRI use that is too activating/ causing sexual dysfunction
Nefazodone (a Serotonin Receptor Antagonist… inhibits 5HT2 family of receptors)
-BLACK BOX WARNING for risk of liver failure
(Lecture 1)
This MAOI, used for atypical depression in patients refractory to other anti-depressants is considered LAST LINE agent
Tranylcypromine
(Lecture 1)
This NDRI is contraindicated for PATIENTS AT RISK FOR SEIZURES, those with a hx of eating disorders, and those withdrawing from alcohol or benzos
Bupropion
(Lecture 1)
This anti-depressant is “not likely” to cause sexual dysfunction
Bupropion
(Lecture 1)
These 2 anti-depressants are “less likely” to cause weight gain
Bupropion
and
Fluoxetine
(Lecture 1)
These 3 are good choices for antidepressants which avoid/reduce somnolence
Mirtazapine
Paroxetine
and
Trazodone
(Lecture 1)
These anti-depressants can increase energy
- Bupropion or an SNRI
- Fluoxetine and Sertraline are more activating than other SSRIs
(Lecture 1)
These anti-depressant classes are recommended if the PT is currently experiencing anxiety; this drug can increase anxiety
- SSRI or SNRIs are recommended in anxiety
- Bupropion can increase anxiety
(Lecture 1)
These two anti-depressants can be used in depression plus fibromyalgia or neuropathic pain
Duloxetine
or
Venlafaxine
(Lecture 1)
These two anti-depressants have indication for diabetic neuropathy
Amitriptyline
and
Imipramine
(Lecture 2) This class of drugs is DOC for parkinsonism induced by drugs (anti-psychotics and Metoclopromide (Antiemetic))
Anticholinergics
EX: Benztropine (useful for control of EPS other than tardive dyskinesia)
and
Trihexyphenidyl
(Lecture 2)
This drug may be the best choice for patients with mild-moderate Parkinson’s
Controlled release Carbidopa/Levodopa
-no measurable effect on “freezing”
(immediate release version for ERRATIC disease)
(Lecture 2) drug class considered first line mono-therapy in most symptomatic Parkinson's Pts because of less dyskinesias and not oxidizing into free radicals
Dopamine Agonists
- may delay need for Levodopa for several years
- can cause daytime sleepiness
- USE WITH CAUTION IN PTS W/ PSYCHOSIS OR DEMENTIA (may worsen sx)
(Lecture 2)
IMPROVEMENT OF MOTOR DISABILITY in Parkinson’s is better with which drug?
Levodopa
- greatest effect on bradykinesia and rigidity
- initial therapy for elderly (>70), dementia, and patients with significant cognitive impairment
- wearing-off and on-off phenomena
(Lecture 2) LESSENING OF MOTOR COMPLICATIONS in Parkinson's is better with which class of drugs?
Dopamine agonists
EX: Bromocriptine; Pramipexole; Ropinirole; Apomorphine
(Lecture 2)
Treatment strategy for Parkinson’s PT with side effect of Dyskinesia?
- Reduce L-Dopa dose
- Add amantadine (NMDA receptor Inhibitor) or an anticholinergic
(Lecture 2)
Treatment strategy for Parkinson’s PT with side effect of severe motor fluctuations despite optimal oral therapy?
consider SQ apomorphine (a short acting D2 selective Dopamine angonist)
- FOR ACUTE, INTERMITTENT TX OF “OFF” EPISODES
- IF NO DOSING >1 WEEK, RESTART AT 0.2 ml INCREASE
or
Duodopa
(Lecture 2) This class of drug is most useful in Parkinson's PTs with tremors, but side effects and CIs are a concern
Anticholinergics
(Lecture 2)
Stimulation of this family of dopamine receptors improves rigidity and bradykinesia
D2
(Lecture 2)
These 2 non-ergot D2 and D3 selective dopamine Agonists are used in mild Parkinsons and both have indication for Restless Leg Syndrome
Pramipexole
-POSSIBLE NEURO-PROTECTIVE EFFECT
and
Ropinirole